Health related costs of smoking from the viewpoint of the Health Insurance Fund in Hungary

Gresz, Miklós; Nagy, Júlia A.; Freyler, Petra

doi:10.1556/oh.2012.29280

Cited by 2 publications

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In England, Germany, Hungary and Spain data on the number of days lost per smoker came from the published sources 56, 57, 58, 59, whereas in the Netherlands, reports on health‐care figures were available to derive the number of lost work‐days 60. Average hourly wage was obtained in all cases through search and analysis of national databases 61, 62, 63, 64.…”

Section: Methodsmentioning

confidence: 99%

Estimates of costs for modelling return on investment from smoking cessation interventions

Trapero-Bertran

Leidl²,

Muñoz

et al. 2018

Addiction

View full text Add to dashboard Cite

Background and aimsModelling return on investment (ROI) from smoking cessation interventions requires estimates of their costs and benefits. This paper describes a standardized method developed to source both economic costs of tobacco smoking and costs of implementing cessation interventions for a Europe‐wide ROI model [European study on Quantifying Utility of Investment in Protection from Tobacco model (EQUIPTMOD)].DesignFocused search of administrative and published data. A standardized checklist was developed in order to ensure consistency in methods of data collection.Setting and participantsAdult population (15+ years) in Hungary, Netherlands, Germany, Spain and England. For passive smoking‐related costs, child population (0–15 years) was also included.MeasurementsCosts of treating smoking‐attributable diseases; productivity losses due to smoking‐attributable absenteeism; and costs of implementing smoking cessation interventions.FindingsAnnual costs (per case) of treating smoking attributable lung cancer were between €5074 (Hungary) and €52 106 (Germany); coronary heart disease between €1521 (Spain) and €3955 (Netherlands); chronic obstructive pulmonary disease between €1280 (England) and €4199 (Spain); stroke between €1829 (Hungary) and €14 880 (Netherlands). Costs (per recipient) of smoking cessation medications were estimated to be: for standard duration of varenicline between €225 (England) and €465 (Hungary); for bupropion between €25 (Hungary) and €220 (Germany). Costs (per recipient) of providing behavioural support were also wide‐ranging: one‐to‐one behavioural support between €34 (Hungary) and €474 (Netherlands); and group‐based behavioural support between €12 (Hungary) and €257 (Germany). The costs (per recipient) of delivering brief physician advice were: €24 (England); €9 (Germany); €4 (Hungary); €33 (Netherlands); and €27 (Spain).ConclusionsCosts of treating smoking‐attributable diseases as well as the costs of implementing smoking cessation interventions vary substantially across Hungary, Netherlands, Germany, Spain and England. Estimates for the costs of these diseases and interventions can contribute to return on investment estimates in support of national or regional policy decisions.

show abstract

Section: Methodsmentioning

confidence: 99%

Estimates of costs for modelling return on investment from smoking cessation interventions

Trapero-Bertran

Leidl²,

Muñoz

et al. 2018

Addiction

View full text Add to dashboard Cite

show abstract

Change in secondhand smoke levels in a public hospital in Budapest following anti-smoking policy implementation in 2011

Tárnoki

Csáthy

et al. 2013

Orvosi Hetilap

View full text Add to dashboard Cite

show abstract

Health related costs of smoking from the viewpoint of the Health Insurance Fund in Hungary

Abstract: The authors estimated a total of 864.4 billion HUF loss to the Hungarian economy due to smoking.

Cited by 2 publications

References 1 publication

Estimates of costs for modelling return on investment from smoking cessation interventions

Estimates of costs for modelling return on investment from smoking cessation interventions

Change in secondhand smoke levels in a public hospital in Budapest following anti-smoking policy implementation in 2011

Contact Info

Product

Resources

About